eye disease

Showing 2 posts of 2 posts found.


Novartis’ Lucentis secures European approval for infants with rare eye disease

September 6, 2019
Medical Communications, Sales and Marketing Europe, Lucentis, Novartis, eye disease, pharma

Novartis has made the surprise announcement that its VEGF inhibitor Lucentis (ranibizumab) has been awarded marketing authorisation from the European …

Dompé gives the FDA its first approved neurotrophic keratitis treatment

August 24, 2018
Medical Communications, Sales and Marketing Dompe, FDA, Oxervate, eye disease, pharma

Milan-based biotech firm Dompé has revealed that the FDA has awarded approval in the US to its Oxervate (cenegermin-bkbj ophthalmic …

Latest content